Prior analyses have shown that blood biomarkers of coagulation and inflammation (i.e., fibrinogen and D-dimer relative to C-reactive protein) can help predict cognitive defects in patients hospitalized for COVID-19 up to 12 months after infection7. The gene discussed is CRP; the disease is COVID-19.